Search research articles
Contact Us
Filters
Showing results (671-680 of 709) with videos related to
Page
of 71
Sort By:
Earth, Planets, and Space : EPS
|
January 28, 2020
Ultraviolet imager on Venus orbiter <i>Akatsuki</i> and its initial results
Atsushi Yamazaki, Manabu Yamada, Yeon Joo Lee, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions
|
March 18, 2025
Cutting balloon versus standard balloon for lesion preparation of drug-coated balloon treatment in de-novo coronary artery lesions: Rationale and Design of the Randomized NATURE trial
Masafumi Ono, Taku Asano, Masahiko Noguchi, et al.
Drugs - Real World Outcomes
|
July 19, 2023
Cabozantinib for Advanced Hepatocellular Carcinoma in the Latest Real-World Practice: A Multicenter Retrospective Analysis
Hiroaki Kanzaki, Sadahisa Ogasawara, Tomomi Okubo, et al.
International Journal of Clinical Oncology
|
June 15, 2022
Liver biopsy technique in the era of genomic cancer therapies: a single-center retrospective analysis
Yusuke Ozeki, Naoya Kanogawa, Sadahisa Ogasawara, et al.
Liver Cancer
|
October 1, 2020
Potential of Lenvatinib for an Expanded Indication from the REFLECT Trial in Patients with Advanced Hepatocellular Carcinoma
Susumu Maruta, Sadahisa Ogasawara, Yoshihiko Ooka, et al.
Cancer Medicine
|
February 18, 2026
Durable Disease Control With Atezolizumab Plus Bevacizumab but Limited Post-Progression Outcomes: A Multicenter Real-World Study in Advanced Hepatocellular Carcinoma
Masanori Inoue, Sadahisa Ogasawara, Kazuhisa Asahara, et al.
Case Reports in Oncology
|
December 11, 2023
Controlling Major Portal Vein Invasion Progression during Lenvatinib Treatment by Carbon-Ion Radiotherapy in Patients with Advanced Hepatocellular Carcinoma
Ryoi Yoshida, Keisuke Koroki, Hirokazu Makishima, et al.
Liver Cancer
|
October 21, 2020
Analyses of Intermediate-Stage Hepatocellular Carcinoma Patients Receiving Transarterial Chemoembolization prior to Designing Clinical Trials
Keisuke Koroki, Sadahisa Ogasawara, Yoshihiko Ooka, et al.
BMJ Open
|
April 9, 2022
Durvalumab with or without tremelimumab combined with particle therapy for advanced hepatocellular carcinoma with macrovascular invasion: protocol for the DEPARTURE phase Ib trial
Sadahisa Ogasawara, Keisuke Koroki, Hirokazu Makishima, et al.
Scientific Reports
|
March 6, 2021
The impact of FGF19/FGFR4 signaling inhibition in antitumor activity of multi-kinase inhibitors in hepatocellular carcinoma
Hiroaki Kanzaki, Tetsuhiro Chiba, Junjie Ao, et al.
Page
of 71
Search research articles
Search
Showing results (671-680 of 709) with videos related to
Sort By:
Page
of 71
Earth, Planets, and Space : EPS
|
January 28, 2020
Ultraviolet imager on Venus orbiter <i>Akatsuki</i> and its initial results
Atsushi Yamazaki, Manabu Yamada, Yeon Joo Lee, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions
|
March 18, 2025
Cutting balloon versus standard balloon for lesion preparation of drug-coated balloon treatment in de-novo coronary artery lesions: Rationale and Design of the Randomized NATURE trial
Masafumi Ono, Taku Asano, Masahiko Noguchi, et al.
Drugs - Real World Outcomes
|
July 19, 2023
Cabozantinib for Advanced Hepatocellular Carcinoma in the Latest Real-World Practice: A Multicenter Retrospective Analysis
Hiroaki Kanzaki, Sadahisa Ogasawara, Tomomi Okubo, et al.
International Journal of Clinical Oncology
|
June 15, 2022
Liver biopsy technique in the era of genomic cancer therapies: a single-center retrospective analysis
Yusuke Ozeki, Naoya Kanogawa, Sadahisa Ogasawara, et al.
Liver Cancer
|
October 1, 2020
Potential of Lenvatinib for an Expanded Indication from the REFLECT Trial in Patients with Advanced Hepatocellular Carcinoma
Susumu Maruta, Sadahisa Ogasawara, Yoshihiko Ooka, et al.
Cancer Medicine
|
February 18, 2026
Durable Disease Control With Atezolizumab Plus Bevacizumab but Limited Post-Progression Outcomes: A Multicenter Real-World Study in Advanced Hepatocellular Carcinoma
Masanori Inoue, Sadahisa Ogasawara, Kazuhisa Asahara, et al.
Case Reports in Oncology
|
December 11, 2023
Controlling Major Portal Vein Invasion Progression during Lenvatinib Treatment by Carbon-Ion Radiotherapy in Patients with Advanced Hepatocellular Carcinoma
Ryoi Yoshida, Keisuke Koroki, Hirokazu Makishima, et al.
Liver Cancer
|
October 21, 2020
Analyses of Intermediate-Stage Hepatocellular Carcinoma Patients Receiving Transarterial Chemoembolization prior to Designing Clinical Trials
Keisuke Koroki, Sadahisa Ogasawara, Yoshihiko Ooka, et al.
BMJ Open
|
April 9, 2022
Durvalumab with or without tremelimumab combined with particle therapy for advanced hepatocellular carcinoma with macrovascular invasion: protocol for the DEPARTURE phase Ib trial
Sadahisa Ogasawara, Keisuke Koroki, Hirokazu Makishima, et al.
Scientific Reports
|
March 6, 2021
The impact of FGF19/FGFR4 signaling inhibition in antitumor activity of multi-kinase inhibitors in hepatocellular carcinoma
Hiroaki Kanzaki, Tetsuhiro Chiba, Junjie Ao, et al.
Page
of 71